Pharmaceutical News and Articles

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with Keytruda (pembrolizumab) After Neoadjuvant Keytruda and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

Merck (NYSE MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (Nasdaq MRNA), today announced the initiation of INTerpath-009, a pivo

Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases

SAN FRANCISCO, Oct. 29, 2024. Nektar Therapeutics today announced the publication of peer-reviewed data from two Phase 1b studies in Nature Communications highl

Childhood Attention Issues Show Links to Later Risk for Psychosis, Schizophrenia

Most kids with attention issues won t go on to develop serious psychiatric conditions like psychosis or schizophrenia. However, a new study finds poor attention

How AI Might Help Men Fighting Prostate Cancer

Artificial intelligence might be able to help doctors detect the prostate cancers most likely to be life-threatening to men, a new study suggests. An AI program

Clinical Practice Guideline Updated for Migraine, Tension-Type Headache

In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Oct. 29 in the Anna

ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma

For patients with asthma, inhaled corticosteroids (ICS) combined with short-acting agonists (SABA) and ICS combined with the long-acting agonist formoterol are

Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries

Among privately insured patients, there was a doubling in the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as antiobesity treatment from 2022 to

USPSTF Recommends Screening for Domestic Violence in Pregnant, Postpartum Women

The U.S. Preventive Services Task Force recommends screening for intimate partner violence (IPV) in pregnant and postpartum women and women of reproductive age.

Clinicians Often Fail to Rescue Women With Complications After High-Risk Surgery

Clinicians fail to rescue female patients with complications after high-risk vascular and cardiac surgeries more often than male patients, according to a study

Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration